Operates a digital professional network for US physicians, offering telehealth tools, hiring and pharma marketing services.
Operates a digital professional network for US physicians, offering telehealth tools, hiring and pharma marketing services.
Doctors use the network free, and pharmaceutical companies pay annual contracts to reach them with ads and educational content, so income depends on drugmakers' marketing budgets and on how many physicians visit. Health systems also pay to recruit. Free tools such as telehealth keep physicians returning.
Moat: narrow (network effects, data, installed base). Large share of US physicians on the network gives strong network effects and pharma advertiser demand.
Headquarters: San Francisco, California, United States · Founded: 2011 · Employees: 880
Size Doximity (DOCS) is a United States Information Technology company (Packaged Software) with a market value of $5.47B, the 1112th largest of 3,085 United States companies the cockpit tracks. Shares closed at $30.67 on 18 Nov 2026.
Performance Over six months the shares gained 59.2%, against +10.4% for the median peer and -2.2% for the United States market (cap-weighted) — 5th highest of 19 in its peer set.
Growth Revenue grew 6.5% over the last twelve months (peer median +13.5%); the operating margin is 26.7% (peer median 12.8%).
Valuation It trades at 21.2× forward earnings against a peer median of 18.7× (8th most expensive of 18).
Price implies For today's price to make sense, revenue must grow about 17% a year for seven years (Req g). Recent delivered growth is +26%, so the hurdle is -9 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 50.6 points above its cost of capital (11.5% WACC).
Short interest Short interest is 5.5% of the free float (30 Oct 2026).
Next results Next results expected around 11 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $662M | $645M | $570M | $475M | $419M |
| Revenue growth | — | +13% | +20% | +13% | — |
| Gross profit | $566M | $575M | $515M | $425M | $366M |
| EBITDA | $201M | $236M | $241M | $183M | $138M |
| Net income | $140M | $196M | $223M | $148M | $113M |
| Free cash flow | $297M | $318M | $267M | $178M | $178M |
| Capital expenditure | $8.96M | $8.96M | $6.53M | $5.80M | $6.18M |
| Total debt | $9.15M | $10.2M | $12.4M | $14.5M | $15.6M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Doximity DOCS | $5.47B | +59% | +6% | 27% | 21.2× | 17.0% |
| Veeva Systems VEEV | $44.9B | +68% | +16% | 30% | 28.7× | 23.1% |
| Iqvia IQV | $42.5B | +50% | +9% | 14% | 18.7× | 16.8% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | DOCS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -8.0% | -4.5% | 9th lowest of 21 |
| 6-month return | +59.2% | +10.4% | 5th highest of 19 |
| Distance from 52-week high | -40.8% | -27.2% | 5th lowest of 21 |
| Revenue growth (TTM) | +6.5% | +13.5% | 7th lowest of 21 |
| Operating margin | 26.7% | 12.8% | 4th highest of 21 |
| Forward P/E | 21.2× | 18.7× | 8th most expensive of 18 |
| Growth the price implies (Req g, 7 yrs) | 17.0% | 14.5% | 8th most demanding of 17 |
| Growth delivered (Del g) | +25.5% | +15.3% | 5th highest of 17 |
| Hurdle (Req g minus delivered) | -8.6 pp | -4.4 pp | 7th least demanding of 17 |
| ROIC minus cost of capital | +50.6 pp | +0.3 pp | highest of 21 |
| EV / EBITDA | 23.6× | 14.5× | 3rd most expensive of 13 |
| Net debt / EBITDA | -3.5× | 0.6× | 2nd least indebted of 14 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Doximity DOCS | United States | $5.47B | +59% | +6% | 27% | 21.2× | 17.0% | +25.5% |
| SenseTime 0020.HK | Hong Kong | $5.53B | -43% | +31% | -51% | n/a | n/a | n/a |
| AutoStore AUTO.OL | Norway | $5.39B | +16% | +27% | 32% | 27.1× | 19.2% | +27.0% |
| Open Text OTEX.TO | Canada | $5.55B | +5% | -1% | 23% | 6.0× | -6.8% | +10.8% |
| Sezzle SEZL | United States | $5.36B | +116% | +39% | 42% | 23.7× | 27.4% | +50.3% |
| Dolby Laboratories DLB | United States | $5.32B | +5% | +5% | 23% | 12.9× | 4.9% | +2.1% |
| ACI Worldwide ACIW | United States | $5.30B | +22% | +2% | 15% | 18.7× | 13.7% | +6.3% |
| Waystar WAY | United States | $5.30B | +43% | +21% | 24% | 15.3× | 7.6% | +16.0% |
| Hundsun Technologies 600570.SS | China | $5.66B | -21% | -5% | 9% | 27.8× | 33.5% | +7.0% |
| BILL BILL | United States | $5.67B | +72% | +7% | 7% | 16.1× | 26.2% | +47.3% |
| Varonis Systems VRNS | United States | $5.68B | +58% | +18% | -26% | 136.4× | 23.7% | +16.3% |
| Shanghai Baosight Software 600845.SS | China | $5.71B | -28% | +11% | 10% | 30.0× | 6.2% | +1.4% |
| Octave Intelligence OCTV | United States | $5.72B | n/a | +1% | 20% | 15.4× | 17.5% | +1.3% |
| iSoftStone Information Technology (Group) 301236.SZ | China | $5.20B | -12% | +13% | 0% | 106.6× | n/a | n/a |
| Topicus.com TOI.V | Canada | $5.79B | 0% | +24% | 16% | 20.6× | -0.6% | +26.5% |
| Giant Network 002558.SZ | China | $5.16B | -39% | +105% | 48% | 8.9× | -3.7% | +17.9% |
| NIQ Global Intelligence NIQ | United States | $5.13B | +103% | +9% | 10% | 13.2× | 3.1% | +14.6% |
| Beijing Deepzero Technology 2947.HK | Hong Kong | $5.13B | n/a | +31% | 1% | n/a | n/a | n/a |
| BlackBerry BB.TO | Canada | $5.02B | +44% | +14% | 16% | 40.5× | 33.8% | -8.6% |
| MiniMax 0100.HK | Hong Kong | $5.00B | -84% | +159% | -407% | n/a | n/a | n/a |
| RingCentral RNG | United States | $6.01B | +64% | +5% | 9% | 13.2× | 15.3% | +16.3% |